30% hos patienter med mild til moderat nedsat nyrefunktion og 60% hos patienter med alvorligt nedsat nyrefunktion samt hæmodialyse - krævende patienter med nyresygdom i slutstadiet, mens cmax var upåvirket.
Renal impairment The AUC of lacosamide was increased by approximately 30% in mildly and moderately and 60% in severely renal impaired patients and patients with endstage renal disease requiring hemodialysis compared to healthy subjects, whereas cmax was unaffected.